Accessibility Menu
 

Park Ha Biological Technology

(NASDAQ) BYAH

Current Price$1.20
Market Cap$38.28M
Since IPO (2024)-99%
5 YearN/A
1 Year-100%
1 Month+9%

Park Ha Biological Technology Financials at a Glance

Market Cap

$38.28M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$-41.38

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$1.20

Volume

28,301.704

Open

$1.13

Previous Close

$1.20

Daily Range

$1.10 - $1.20

52-Week Range

$0.93 - $2074.50

BYAH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Park Ha Biological Technology

Industry

Specialty Retail

Employees

41

CEO

Xiao Qiu Zhang

Headquarters

Wuxi, 214000, CN

BYAH Financials

Key Financial Metrics (TTM)

Gross Margin

91%

Operating Margin

-10%

Net Income Margin

-10%

Return on Equity

-886%

Return on Capital

-6%

Return on Assets

-4%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$38.28M

Shares Outstanding

33.87M

Volume

28.30K

Avg. Volume

305.35K

Financials (TTM)

Gross Profit

$2.38M

Operating Income

$24.15M

EBITDA

$24.04M

Operating Cash Flow

$85.85K

Capital Expenditure

$88.82K

Free Cash Flow

$2.97K

Cash & ST Invst.

$3.79M

Total Debt

$180.17K

Park Ha Biological Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.29M

N/A

Gross Profit

$1.11M

N/A

Gross Margin

86.16%

N/A

Market Cap

$38.28M

N/A

Market Cap/Employee

$1.23M

N/A

Employees

31

N/A

Net Income

$4.53M

N/A

EBITDA

$4.34M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.61M

N/A

Accounts Receivable

$1.30M

N/A

Inventory

$84.60K

N/A

Long Term Debt

$75.92K

N/A

Short Term Debt

$104.25K

N/A

Return on Assets

-4.09%

N/A

Return on Invested Capital

-5.93%

N/A

Free Cash Flow

$246.19K

N/A

Operating Cash Flow

$159.58K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CGTLCreative Global Technology Holdings Limited Ordinary Shares
$1.13-0.88%
REBNReborn Coffee, Inc.
$2.44-5.24%
BTBDBT Brands, Inc.
$1.80-7.69%
MRMMEDIROM Healthcare Technologies Inc.
$1.22+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.84+2.39%
GBTGGlobal Business Travel Group
$9.34+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.69-0.00%

Questions About BYAH

What is the current price of Park Ha Biological Technology?

Park Ha Biological Technology is trading at $1.20 per share.

What is the 52-week range for Park Ha Biological Technology?

Over the past 52 weeks, Park Ha Biological Technology has traded between $0.93 and $2,074.50.

How much debt does Park Ha Biological Technology have?

As of the most recent reporting period, Park Ha Biological Technology reported total debt of $180,169.

How much cash does Park Ha Biological Technology have on hand?

Park Ha Biological Technology reported $3.79M in cash and cash equivalents in its most recent financial results.

What is Park Ha Biological Technology’s dividend yield?

Park Ha Biological Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.